FLOT1 and metastatic malignant neoplasm in the lymph nodes: High levels of FLOT1 expression also predicted poorer overall survival (P = 0.038; HR (95% CI) = 1.88 (1.02–3.48)) in the subgroup of patients with lymph node metastasis (Figure 1F).